EUVIMEDEUVIMED entdecken
Crossref

Cisplatin Conjugated with Vinylsulfonamide Cross-Links Pyruvate Kinase M2 to Trigger Ferroptosis

Zhongtang Yu iD, Hailong Zhao, Caiping Tian, Xiuwen Yu, You-Liang Zeng, Yu Liu, Jiaxuan Chen, Qiong Wu, Jing Yang, Yue Zheng, Zong-Wan Mao iD

Journal of the American Chemical Society · 04.11.2026 · 148 (43) · 47582-47596

DOI: 10.1021/jacs.6c19160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 26.10.2026. Verfasst von Zhongtang Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Institute for Frontier Interdisciplinary Research in Health Sciences…. Hauptthemen laut MEDLINE: Cisplatin, Antineoplastic Agents, Ferroptosis, Sulfonamides. Die Arbeit nennt 76 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin serves as a first-line chemotherapeutic agent due to its DNA binding property. However, this intrinsic electrophilicity drives off-target interactions with proteins, which compromises anticancer efficacy, and also suggests the presence of unexplored targets. To identify platinum-binding proteins, a class of platinum(II) complexes containing a covalent vinylsulfonamide group were designed to provide stronger affinity for target engagement. By using competitive chemical proteomics technology, pyruvate kinase M2 (PKM2) was identified as the direct target of Pt1. The intracellular binding involved the recognition of the Cys49 pocket via cis-platinum moiety, which was strengthened by the synergistic event of platinum-centered ligand exchange and vinylsulfonamide-mediated covalent anchoring. This effective multimodal interaction disrupted PKM2 oligomerization and promoted its nuclear translocation. Subsequently, Pt1 induced ferroptosis via the PKM2-HMOX1 axis, further enhanced by mitochondrial oxidative stress. In xenograft models, Pt1 exhibited antitumor efficacy comparable to that of cisplatin, along with lower hepatotoxicity. This study presents a cisplatin conjugate that induces ferroptosis through intramolecular protein cross-linking, providing a synergistic coordination-covalent strategy for nonclassical platinum-based therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinAntineoplastic AgentsFerroptosisSulfonamidesPyruvate KinaseVinyl CompoundsMembrane ProteinsCross-Linking ReagentsCarrier ProteinsHumansAnimalsMiceThyroid Hormone-Binding ProteinsDrug Screening Assays, AntitumorCell Line, TumorCell Proliferation

Substanzen

CisplatinAntineoplastic AgentsSulfonamidesPyruvate KinaseVinyl CompoundsThyroid Hormone-Binding ProteinsMembrane ProteinsCross-Linking ReagentsCarrier Proteins

Autor:innen und Institutionen

  • MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Institute for Frontier Interdisciplinary Research in Health Sciences and Technology, IGCME, GBRCE for Functional Molecular Engineering, Su…
  • State Key Laboratory of Proteomics, National Center for Protein Sciences, Beijing, Beijing102206, China.
  • International Academy of Phronesis Medicine (Guangdong), Guangzhou510535, China.
  • School of Bioscience and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou510006, China.
  • School of Pharmacy, Guangdong Engineering Technology Research Center of Molecular Probe and Biomedicine Imaging, Guangdong Pharmaceutical University, Guangzhou510006, China.
  • Guangzhou National Laboratory, Guangzhou International Bio-Island, Guangzhou510005, China.

ORCID-Profile: Zhongtang Yu, Zong-Wan Mao

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Yu, Z., Zhao, H., Tian, C., Yu, X., Zeng, Y. L., Liu, Y., Chen, J., Wu, Q., Yang, J., Zheng, Y., & Mao, Z. W. (2026). Cisplatin Conjugated with Vinylsulfonamide Cross-Links Pyruvate Kinase M2 to Trigger Ferroptosis. Journal of the American Chemical Society, 148(43), 47582-47596. https://doi.org/10.1021/jacs.6c19160

Vancouver

Yu Z, Zhao H, Tian C, Yu X, Zeng YL, Liu Y, et al. Cisplatin Conjugated with Vinylsulfonamide Cross-Links Pyruvate Kinase M2 to Trigger Ferroptosis. Journal of the American Chemical Society. 2026;148(43):47582-47596. doi:10.1021/jacs.6c19160

BibTeX
@article{Yu2026,
  author = {Yu, Zhongtang and Zhao, Hailong and Tian, Caiping and Yu, Xiuwen and Zeng, You-Liang and Liu, Yu and Chen, Jiaxuan and Wu, Qiong and Yang, Jing and Zheng, Yue and Mao, Zong-Wan},
  title = {Cisplatin Conjugated with Vinylsulfonamide Cross-Links Pyruvate Kinase M2 to Trigger Ferroptosis},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  volume = {148},
  number = {43},
  pages = {47582--47596},
  doi = {10.1021/jacs.6c19160}
}
Kostenlos starten →